Care Access, a global leader in clinical research dedicated to advancing the future of medicine, is bringing its Heart & Kidney Health Screening initiative to Glendale, Arizona. The program aims to raise awareness and offer testing for key health risk…
Almirall, S.A. (ALM), a global biopharmaceutical company based in Barcelona, today reported its financial results for the first nine months of 2024. The company posted strong sales growth, primarily driven by its dermatology business, particularly the biologics portfolio in Europe.…
Oncoinvent ASA, a clinical-stage company developing alpha emitter therapies for solid cancers, today reported interim data from the Phase 1/2a trials of Radspherin® for the treatment of peritoneal carcinomatosis. Recruitment for these studies concluded at the end of 2023, with…
Novotech, a full-service global contract research organization (CRO), has been honored with multiple awards at the 2024 Clinical Trials Arena Excellence Awards. These prestigious accolades recognize Novotech’s achievements in business development, innovation, and marketing, underscoring the company’s commitment to advancing…
A2 Biotherapeutics, Inc. (A2 Bio), a clinical-stage cell therapy company developing innovative logic-gated cell therapies to selectively target tumor cells while sparing normal cells, today presented updates on its Tmod™ CAR T-cell clinical programs at the 39th Annual Meeting of…
In recognition of National Nurse Practitioner Week (November 10-16), Lindora is honoring the contributions of nurse practitioners and wellness professionals with a special offer. There are over 385,000 nurse practitioners (NPs) licensed in the U.S., according to the American Association…
Chemed Corporation (NYSE: CHE) today announced that its Board of Directors has authorized an additional $300 million for stock repurchases under the company’s existing share repurchase program. These repurchases will be funded with a mix of cash generated from operations…
November marks American Diabetes Month®, an important time to raise awareness about diabetes and support the 1.2 million new diabetes diagnoses in the U.S. each year, along with the more than 38 million Americans living with the disease. To help…
Butterfly Network, Inc. (NYSE: BFLY), a leader in digital health and portable ultrasound technology, has announced that its third-generation handheld ultrasound device, the Butterfly iQ3™, has been honored with the Best Medical Technology Award at the 2024 Prix Galien USA…
Tempus AI, Inc. (NASDAQ: TEM), a leader in applying artificial intelligence to drive advancements in precision medicine and patient care, today announced that nine of its abstracts have been accepted for presentation at the Society for Immunotherapy of Cancer’s (SITC)…
Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) announced that on November 8, 2024, its Compensation Committee granted inducement awards to seven new employees under the company’s 2020 Inducement Plan. These awards consist of non-qualified stock options to purchase 56,100 shares of common…
Baxter International Inc. (NYSE: BAX), a global leader in medical technology, announced today its financial results for the third quarter of 2024, highlighting strong performance despite ongoing challenges. “Despite facing some headwinds, Baxter delivered positive results in the third quarter…